Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system(BDDCS)

被引:0
|
作者
LI Ji [1 ]
Caroline A.Larregieu [2 ]
Leslie Z.Benet [2 ]
机构
[1] Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University
[2] Department of Bioengineering & Therapeutic Science, University of California
关键词
Biopharmaceutics Drug Disposition Classification System(BDDCS); Natural products(NPs); Dose number; Solubility and extent of metabolism;
D O I
暂无
中图分类号
R915 [药物生物学];
学科分类号
1007 ;
摘要
Natural products(NPs) are compounds that are derived from natural sources such as plants, animals, and microisms. Therapeutics has benefited from numerous drug classes derived from natural product sources. The Biopharmaceutics Drug position Classification System(BDDCS) was proposed to serve as a basis for predicting the importance of transporters and enzymes in determining drug bioavailability and disposition. It categorizes drugs into one of four biopharmaceutical classes according to their water solubility and extent of metabolism. The present paper reviews 109 drugs from natural product sources: 29% belong to class 1(high solubility, extensive metabolism), 22% to class 2(low solubility, extensive metabolism), 40% to class 3(high solubility, poor metabolism), and 9% to class 4(low solubility, poor metabolism). Herein we evaluated the characteristics of NPs in terms of BDDCS class for all 109 drugs as wells as for subsets of NPs drugs derived from plant sources as antibiotics. In the 109 NPs drugs, we piled 32 drugs from plants, 50%(16) of total in class 1, 22%(7) in class 2 and 28%(9) in class 3, none found in class 4; Meantime, the antibiotics were found 5(16%) in class 2, 22(71%) in class 3, and 4(13%) in class 4; no drug was found in class 1. Based on this classification, we anticipate BDDCS to serve as a useful adjunct in evaluating the potential characteristics of new natural products.
引用
收藏
页码:888 / 897
页数:10
相关论文
共 50 条
  • [21] Oral drug absorption and the biopharmaceutics classification system
    Lennernas, H.
    Abrahamsson, B.
    Persson, E. M.
    Knutson, L.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2007, 17 (04) : 237 - 244
  • [22] iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products
    Hastedt, Jayne E.
    Backman, Per
    Cabal, Antonio
    Clark, Andy
    Ehrhardt, Carsten
    Forbes, Ben
    Hickey, Anthony J.
    Hochhaus, Guenther
    Jiang, Wenlei
    Kassinos, Stavros
    Kuehl, Philip J.
    Prime, David
    Son, Yoen-Ju
    Teague, Simon
    Tehler, Ulrika
    Wylie, Jennifer
    MOLECULAR PHARMACEUTICS, 2023, 21 (01) : 164 - 172
  • [23] Polymorphic and Quantum Chemistry Characterization of Candesartan Cilexetil: Importance for the Correct Drug Classification According to Biopharmaceutics Classification System
    de Campos, Debora Priscila
    Silva-Barcellos, Neila Marcia
    Lima, Renata Rodrigues
    Leal Savedra, Ranylson Marcello
    Siqueira, Melissa Fabiola
    Yoshida, Maria Irene
    Mussel, Wagner da Nova
    de Souza, Jacqueline
    AAPS PHARMSCITECH, 2018, 19 (07): : 3019 - 3028
  • [24] Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system
    Wu, CY
    Benet, LZ
    PHARMACEUTICAL RESEARCH, 2005, 22 (01) : 11 - 23
  • [25] Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System
    Chi-Yuan Wu
    Leslie Z. Benet
    Pharmaceutical Research, 2005, 22 : 11 - 23
  • [26] Polymorphic and Quantum Chemistry Characterization of Candesartan Cilexetil: Importance for the Correct Drug Classification According to Biopharmaceutics Classification System
    Débora Priscila de Campos
    Neila Márcia Silva-Barcellos
    Renata Rodrigues Lima
    Ranylson Marcello Leal Savedra
    Melissa Fabíola Siqueira
    Maria Irene Yoshida
    Wagner da Nova Mussel
    Jacqueline de Souza
    AAPS PharmSciTech, 2018, 19 : 3019 - 3028
  • [27] Effects of Uremic Toxins on Transport and Metabolism of Different Biopharmaceutics Drug Disposition Classification System Xenobiotics
    Reyes, Maribel
    Benet, Leslie Z.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (09) : 3831 - 3842
  • [28] Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system
    Lindenberg, M
    Kopp, S
    Dressman, JB
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) : 265 - 278
  • [29] Considerations for application of biopharmaceutics classification system in chicken: Exemplified by seven drugs classification
    Liu, Yang
    Li, Xiangxiu
    Wang, Liping
    Zhang, Yujuan
    Huang, Jinhu
    Wu, Yucheng
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2020, 43 (02) : 179 - 188
  • [30] Feasibility of biowaiver extension to Biopharmaceutics Classification System Class III drug products - Cimetidine
    Jantratid, E
    Prakongpan, S
    Amidon, GL
    Dressman, JB
    CLINICAL PHARMACOKINETICS, 2006, 45 (04) : 385 - 399